UBS lowered the firm’s price target on Molina Healthcare (MOH) to $180 from $260 and keeps a Neutral rating on the shares. Higher cost trends are leading to an uncertain outlook, the analyst tells investors in a research note.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MOH: